A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
GlaxoSmithKline
Rush University Medical Center
Bristol-Myers Squibb
Radiation Therapy Oncology Group
Duke University
National Cancer Institute (NCI)
Duke University